Ligand validation:3OC0

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3OC0 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OC0_NAG_A_794	49%	35%	0.179	0.928	0.76	1.76	-	6	0	0	100%	0.9333
3OC0_NAG_B_794	46%	50%	0.199	0.936	0.72	1.2	-	1	1	0	100%	0.9333
3OC0_NAG_A_793	42%	36%	0.195	0.916	0.74	1.75	-	3	0	0	100%	0.9333
3OC0_NAG_A_796	34%	32%	0.205	0.891	0.85	1.83	1	5	0	0	100%	0.9333
3OC0_NAG_B_796	17%	37%	0.262	0.845	0.86	1.58	1	1	0	0	100%	0.9333
3OC0_NAG_B_793	9%	26%	0.353	0.841	0.7	2.23	-	6	0	0	100%	0.9333
3OC0_NAG_B_797	5%	20%	0.367	0.768	0.45	2.9	-	5	0	0	100%	0.9333
3OC0_NAG_A_795	3%	32%	0.355	0.677	0.62	2.03	-	3	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
3NOX_NAG_A_851	94%	61%	0.07	0.971	0.58	0.91	-	-	0	0	100%	0.9333
3SWW_NAG_A_851	89%	58%	0.082	0.962	0.65	0.94	-	-	0	0	100%	0.9333
4N8E_NAG_B_804	87%	63%	0.073	0.944	0.29	1.12	-	3	0	0	100%	0.9333
3Q0T_NAG_B_851	83%	56%	0.103	0.963	0.63	1.05	-	1	0	0	100%	0.9333
5LDS_NAG_C_1002	100%	69%	0.022	0.994	0.55	0.65	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.